Contract Pharma

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Resilience Acquires Ology Bioservices

Continues expansion with acquisition of biologics manufacturing company.

Tim Wright, Editor, Contract Pharma 04.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

RDIF, Hualan Ink COVID-19 Vaccine Deal

Deal calls for production of over 100 million doses of Sputnik V vaccine in China.

Tim Wright, Editor, Contract Pharma 04.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.

Tim Wright, Editor, Contract Pharma 04.19.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sartorius Expands in the UK

New 58,000-square-foot facility aims to simplify and accelerate the production of downstream processing equipment.

Kristin Brooks 04.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Abenza Chooses North Carolina for New Biologics Manufacturing Site

GMP manufacturing will commence in mid-2022.

Charles Sternberg, Assistant Editor 04.15.21

Biologics, Proteins, Vaccines | Breaking News | Industry News | Information Technology

ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

Aims to provide improved product tracking, scheduling and live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.

Kristin Brooks 04.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Albumedix Completes Commercial-Scale Mfg. Facility Expansion

Will service increasing demand for products and technologies for cell and gene therapies, vaccines, diagnostics, protein and peptide therapeutics.

Kristin Brooks 04.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Biologics Completes Madison Expansion

More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.

Kristin Brooks 04.13.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sanofi Invests in Cutting Edge Vax Production Site in Singapore

The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.

Kristin Brooks 04.12.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Sanofi Acquires Tidal Therapeutics

Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.

Kristin Brooks 04.12.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

Moderna, Catalent Enter Long-Term Strategic Vax Pact

Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.

Kristin Brooks 04.06.21

Sanofi to Build New $700M Flu Vaccine Facility in Canada

Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.

Tim Wright, Editor, Contract Pharma 04.05.21

Biologics, Proteins, Vaccines | Regulatory Affairs

What Will Change at FDA for 2021?

(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?

Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Combined company brings complementary Ribosomal RNA-targeted genetic therapy platforms together.

Kristin Brooks 04.01.21

GSK Supports Manufacture of Novavax’ COVID-19 Vaccine

GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.

Tim Wright, Editor, Contract Pharma 03.31.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Ajinomoto, Bright Peak Enter Immunocytokines Research Pact

Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

CureVac, Celonic Enter COVID-19 Vax Mfg. Pact

Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | cGMP Manufacture

Advanced Analytics Advancing Development of Genetic Vaccines

Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.29.21

Chime Biologics Expands CDMO Capabilities

Completes $190 million financing round to accelerate capacity expansion.

Tim Wright, Editor, Contract Pharma 03.29.21

Jubilant, Novavax Enter COVID-19 Vaccine Partnership

Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.

Tim Wright, Editor, Contract Pharma 03.29.21

CyanVac and Exothera Enter COVID-19 Vaccine Partnership

CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.

Tim Wright, Editor, Contract Pharma 03.25.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Development

ProBioGen, Nobelpharma Enter Mfg. Agreement for Vax Project

To leverage ProBioGen’s vaccine development platform consisting of its AGE1.CR.pIX suspension cell line and its high performance cell culture medium.

Kristin Brooks 03.24.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioCentriq and Kytopen Enter Cell Therapy Partnership

To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.

Tim Wright, Editor, Contract Pharma 03.23.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec, Takeda Enter Multi-RNA Target Alliance

To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.

Kristin Brooks 03.22.21

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Trials & Filings

CureVac Expands Late-stage Trials of COVID Vax Candidate

Further analysis to determine efficacy of the vaccine candidate for new virus variants.

Krisitn Brooks 03.22.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

RDIF & Stelis Enter Covid-19 Vaccine Supply Deal

Partner to supply 200 million doses of the Sputnik V vaccine.

Tim Wright, Editor, Contract Pharma 03.19.21

Genopis Renamed Wacker Biotech US

Plasmid DNA contract manufacturer was recently acquired by Wacker.

Tim Wright, Editor, Contract Pharma 03.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Fujifilm Selects North Carolina for $2B Bio CDMO Facility

Holly Springs is the location chosen to build the largest cell culture biopharmaceutical CDMO facility in North America.

Tim Wright, Editor, Contract Pharma 03.19.21

Biologics, Proteins, Vaccines | Breaking News | Industry News | Scale-up/Technology Transfer

SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax

Will leverage SUREtechnology Platform to generate stable, high-yield production cell lines needed for human clinical trials.

Kristin Brooks 03.18.21

WuXi Biologics to Acquire CMAB Biopharma Group

Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.

Kristin Brooks 03.18.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Catalent Expands Partnership with J&J

To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.

Tim Wright, Editor, Contract Pharma 03.17.21

WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China

Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.

Tim Wright, Editor, Contract Pharma 03.17.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Northwest Biotherapeutics Adds Production Capacity at UK Facility

Dendritic cell vaccine production capacity for personalized immune therapies increases from about 4 - 6 patients per month to about 40 - 45 patients per month.

Kristin Brooks 03.16.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Selexis, Pandion Enter Antibody Service Agreement

Pandion will leverage Selexis’ SUREtechnology Platform to advance an antibody targeting autoimmune and inflammatory diseases.

Kristin Brooks 03.16.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy

NJ-based cell and gene therapy development and manufacturing center to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.

Kristin Brooks 03.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine

Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 03.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Maravai Expands CDMO Capabilities Through TriLink Biotechnologies

Offers end-to-end mRNA production with the launch of TriLink's plasmid DNA manufacturing services.

Tim Wright, Editor, Contract Pharma 03.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioVaxys, Wuxi Biologics Enter Bioproduction Agreement

To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.

Tim Wright, Editor, Contract Pharma 03.15.21

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

Novavax Confirms Efficacy Against Original and Variant COVID-19 Strains

Final analysis of NVX–CoV2373 in UK trial confirms 96% efficacy against original strain of COVID-19 and 86.3% against the B.1.1.7 variant.

Kristin Brooks 03.12.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions

New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.

Tim Wright, Editor, Contract Pharma 03.09.21

Bio News | Biologics, Proteins, Vaccines | Facilities | Industry News

Arranta Bio Invests in New Manufacturing Facility

Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.

Tim Wright, Editor, Contract Pharma 03.09.21

Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine

Manufacturing to take place at Baxter’s state-of-the-art Halle/Westfalen, Germany facility.

Tim Wright, Editor, Contract Pharma 03.09.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

AGC Biologics Expands Cell and Gene Facility in Italy

Plans call for increased capacities and viral vector suspension capabilities at Milan site.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Celonic to Boost Cell & Gene Therapy Production

Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

Continues to build integrated capabilities platform for cell and gene therapy.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

Virtual ground-breaking ceremony celebrates initiation of expansion to double cell culture capacity and add large scale fill/finish capabilities.

Tim Wright, Editor, Contract Pharma 03.05.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

New 25,000 sq. ft. GMP facility located College Station, TX.

Tim Wright, Editor, Contract Pharma 03.03.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves

Four Female Leaders Appointed to Cell & Gene CDMO

The Center for Breakthrough Medicines makes leadership appointments to fuel company growth.

Tim Wright, Editor, Contract Pharma 03.03.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

WuXi AppTec Completes OXGENE Acquisition

Expands Cell and Gene Therapy service offerings for global customers.

Kristin Brooks 03.02.21

Biologics, Proteins, Vaccines

Vaccines and Return-To-Normalcy

Planning for a future in which COVID-19 won’t simply ‘disappear.’

Ben Locwin, Contributing Editor 03.01.21

FOLLOW:

Search Results for 'Biologics, Proteins, Vaccines'

Contract Service Directory Companies

Featured Companies

April 2021

follow us